Coloplast A/S (OTCMKTS:CLPBY) Reaches New 1-Year Low – Should You Sell?

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) reached a new 52-week low during trading on Tuesday . The stock traded as low as $5.65 and last traded at $5.65, with a volume of 6866 shares changing hands. The stock had previously closed at $5.78.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CLPBY. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Coloplast A/S Trading Up 1.2%

The company has a quick ratio of 1.09, a current ratio of 1.75 and a debt-to-equity ratio of 1.66. The business has a 50-day simple moving average of $6.13 and a 200-day simple moving average of $7.19. The company has a market cap of $13.00 billion, a PE ratio of 41.21, a price-to-earnings-growth ratio of 1.80 and a beta of 0.22.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. Coloplast A/S had a return on equity of 33.15% and a net margin of 7.46%.The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. On average, analysts predict that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.